Instead of four equal quarterly distributions, AstraZeneca insists on two payments per year, with a greater portion announced ...

New migraine drugs less effective than traditional painkillers, triptans, according to global analysis in The BMJ.

Three newer migraine drugs were included in the analysis: lasmiditan (Reyvow), rimegepant (Nurtec), and ubrogepant (Ubrelvy).

The next frame shows the Ubrelvy logo in the backstage hallway along with a blue lit path. Frames six to seven then show Serena Williams walking down the blue lit path, no longer exhibiting migraine ...

The FDA (Food and Drug Administration) recently sent a letter expressing its dissatisfaction with a TV commercial featuring ...

The Food and Drug Administration recently intervened regarding a migraine medication ad featuring tennis superstar Serena ...

A migraine medicine once-endorsed by Serena Williams has come under fire amid claims advertisements oversold it's usefulness.

Migraines and headaches affect billions of people worldwide, and a new study suggests the drug ubrogepant can put a stop to ...

A drugmaker's advertisement featuring Serena Williams is under FDA scrutiny for misleading claims that it can quickly cure ...

The U.S. Food and Drug Administration is taking North Chicago-based drugmaker AbbVie to task, warning in a recent letter that ...

According to a letter released by the FDA, the advertisement makes false or misleading claims about the drug's efficacy in treating migraine pain. The agency added that the ad exaggerates the speed ...

The FDA has faulted AbbVie’s promotion of the migraine drug Ubrelvy, calling the company out for an ad featuring Serena ...